- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Actavis’ Levosert leavepiece implied broader suitability than Mirena and claimed a “25% saving” on acquisition cost. PMCPA ruled…
Public complaint alleged Sanofi failed to disclose clinical trial results for Multaq and Jevtana in line with ABPI/IFPMA…
Anonymous complaint alleged coercive, industry-funded audits/workshops linked to prescribing. Most allegations not proven, but AstraZeneca was found in…
Shield’s corporate site contained publicly accessible promotional content for Feraccru and promotional descriptions of unlicensed pipeline products. PMCPA…
A Versatis budget impact brochure compared “Total NHS cost” vs gabapentin but didn’t clearly define what costs were…
Complaint about omission of prescribing information/obligatory information. PMCPA concluded no breach and that the matter was outwith the…
A Champix GP referral letter pad used by smoking cessation advisers/pharmacists was handed to patients to take to…
PMCPA case AUTH/2401/4/11 (Anonymous v Meda) about promotion of Rhinolast. The matter was ruled outwith the scope of…
Anonymous NHS worker alleged a Biogen MSL promoted Tysabri to an MS patient at a wedding. Panel found…
Complaint about Trajenta online banner claims (“broad range”, “unique convenience”) and legibility of prescribing info link. Panel found…
One real case. One key lesson. Every week — free.